Site Map | Legal Policy | Privacy Policy

 

Email Alert Subscription

If you have already signed up for Ligand Pharmaceuticals, Inc. Email Alerts, please enter your email address in the field below and submit. A confirmation email will be sent. Please click on the link provided in the confirmation email to view your alert subscription.

Email: *
 
This helps Ligand Pharmaceuticals, Inc. prevent automated submissions.
 
News

Ligand Pharmaceuticals Announces First Quarter Results

Ligand Initiates Phase II Trial with LGD-4665 in Idiopathic .......

Upcoming Events

Q1 2008 Ligand Pharmaceuticals Incorporated Earnings Confere...

Susquehanna Financial Group Second Annual SIGnificant Option...

Q4 2007 Ligand Pharmaceuticals Incorporated Earnings Confere...

Investor Relations|News|Presentations & Events|SEC Documents|
Corporate Governance|Email Alerts
LGND - (NASD)
$3.65   + 0.04